{
  "studyId": "CS-12345",
  "title": "A Randomized Study of Drug X Efficacy in Treating Hypertension",
  "description": "This study aims to evaluate the efficacy and safety of Drug X in patients with moderate to severe hypertension compared to standard treatment.",
  "status": "recruiting",
  "studyType": "interventional",
  "phase": "phase3",
  "enrollment": {
    "target": 500,
    "actual": 127
  },
  "dates": {
    "startDate": "2024-01-01",
    "completionDate": "2026-12-31",
    "primaryCompletionDate": "2026-06-30"
  },
  "sponsors": [
    {
      "name": "Pharmaceutical Research Institute",
      "type": "lead"
    },
    {
      "name": "National Health Foundation",
      "type": "collaborator"
    }
  ],
  "principalInvestigator": {
    "name": "Dr. Sarah Johnson",
    "affiliation": "Medical University Hospital",
    "email": "s.johnson@university.edu"
  },
  "conditions": [
    "Hypertension",
    "Cardiovascular Disease"
  ],
  "interventions": [
    {
      "type": "drug",
      "name": "Drug X",
      "description": "Novel antihypertensive medication, 50mg daily"
    },
    {
      "type": "drug",
      "name": "Placebo",
      "description": "Control group placebo"
    }
  ],
  "metadata": {
    "createdAt": "2023-12-01T08:00:00Z",
    "lastUpdated": "2024-01-15T14:30:00Z",
    "version": "2.1",
    "dataSource": "clinical_trials_registry",
    "qualityScore": 92.5
  }
}
